Guru Ownership Trend
Guru Analysis for Agios Pharmaceuticals, Inc. (AGIO)
Agios Pharmaceuticals, Inc. (AGIO), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $15.46 M.
Top institutional holders include Steven Cohen and Louis Moore Bacon.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $27.13 M net outflow during the quarter.
Recent activity highlights Steven Cohen who dramatically increased their stake. Conversely, Cliff Asness reduced exposure by 69.5%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Agios Pharmaceuticals, Inc. (AGIO)
Major holders include Steven Cohen ($5.44 M), Louis Moore Bacon ($4.08 M), Paul Tudor Jones ($1.67 M). According to the latest reported data, 4 tracked investment managers collectively hold approximately 439,271 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $27.13 M, with 3 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited AGIO. The total reported sell value was $36.65 M.
Yes, 1 managers opened new positions in AGIO, and 2 increased their existing holdings. The total reported buy value was $9.52 M.